Kurs & Likviditet
Kalender
2025-02-06 | Bokslutskommuniké 2024 |
2024-11-14 | Kvartalsrapport 2024-Q3 |
2024-07-17 | Kvartalsrapport 2024-Q2 |
2024-05-08 | Kvartalsrapport 2024-Q1 |
2024-04-29 | Ordinarie utdelning ORX 0.00 SEK |
2024-04-26 | Årsstämma 2024 |
2024-02-08 | Bokslutskommuniké 2023 |
2023-11-02 | Kvartalsrapport 2023-Q3 |
2023-10-26 | Extra Bolagsstämma 2023 |
2023-07-18 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-04-19 | Ordinarie utdelning ORX 0.00 SEK |
2023-04-18 | Årsstämma 2023 |
2023-01-26 | Bokslutskommuniké 2022 |
2022-11-03 | Kvartalsrapport 2022-Q3 |
2022-07-14 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-04-22 | Ordinarie utdelning ORX 0.00 SEK |
2022-04-21 | Årsstämma 2022 |
2022-01-27 | Bokslutskommuniké 2021 |
2021-11-03 | Kvartalsrapport 2021-Q3 |
2021-07-15 | Kvartalsrapport 2021-Q2 |
2021-04-29 | Kvartalsrapport 2021-Q1 |
2021-04-14 | Ordinarie utdelning ORX 0.00 SEK |
2021-04-13 | Årsstämma 2021 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-11-04 | Kvartalsrapport 2020-Q3 |
2020-07-16 | Kvartalsrapport 2020-Q2 |
2020-05-19 | Extra Bolagsstämma 2020 |
2020-04-28 | Kvartalsrapport 2020-Q1 |
2020-04-17 | Ordinarie utdelning ORX 0.00 SEK |
2020-04-16 | Årsstämma 2020 |
2020-01-30 | Bokslutskommuniké 2019 |
2019-10-24 | Kvartalsrapport 2019-Q3 |
2019-07-11 | Kvartalsrapport 2019-Q2 |
2019-05-02 | Kvartalsrapport 2019-Q1 |
2019-04-14 | Ordinarie utdelning ORX 0.00 SEK |
2019-04-11 | Årsstämma 2019 |
2019-01-30 | Bokslutskommuniké 2018 |
2018-10-25 | Kvartalsrapport 2018-Q3 |
2018-07-11 | Kvartalsrapport 2018-Q2 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-04-13 | Ordinarie utdelning ORX 0.00 SEK |
2018-04-12 | Årsstämma 2018 |
2018-01-25 | Bokslutskommuniké 2017 |
2017-10-19 | Kvartalsrapport 2017-Q3 |
2017-07-11 | Kvartalsrapport 2017-Q2 |
2017-04-20 | Kvartalsrapport 2017-Q1 |
2017-04-07 | Ordinarie utdelning ORX 0.00 SEK |
2017-04-06 | Årsstämma 2017 |
2017-01-26 | Bokslutskommuniké 2016 |
2016-10-20 | Kvartalsrapport 2016-Q3 |
2016-07-12 | Kvartalsrapport 2016-Q2 |
2016-04-21 | Kvartalsrapport 2016-Q1 |
2016-04-18 | Ordinarie utdelning ORX 0.00 SEK |
2016-04-15 | Årsstämma 2016 |
2016-01-28 | Bokslutskommuniké 2015 |
2015-10-22 | Kvartalsrapport 2015-Q3 |
2015-07-10 | Kvartalsrapport 2015-Q2 |
2015-04-23 | Kvartalsrapport 2015-Q1 |
2015-04-16 | Ordinarie utdelning ORX 0.00 SEK |
2015-04-15 | Årsstämma 2015 |
2015-01-29 | Bokslutskommuniké 2014 |
2014-10-22 | Analytiker möte 2014 |
2014-10-22 | Kvartalsrapport 2014-Q3 |
2014-07-11 | Kvartalsrapport 2014-Q2 |
2014-04-25 | Kvartalsrapport 2014-Q1 |
2014-04-16 | Ordinarie utdelning ORX 0.00 SEK |
2014-04-15 | Årsstämma 2014 |
2014-01-30 | Bokslutskommuniké 2013 |
2013-10-23 | Kvartalsrapport 2013-Q3 |
2013-08-06 | Extra Bolagsstämma 2013 |
2013-07-12 | Kvartalsrapport 2013-Q2 |
2013-04-26 | Kvartalsrapport 2013-Q1 |
2013-04-12 | Ordinarie utdelning ORX 0.00 SEK |
2013-04-11 | Årsstämma 2013 |
2013-03-13 | 15-7 2013 |
2013-01-31 | Bokslutskommuniké 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-09-21 | 15-7 2012 |
2012-07-13 | Extra Bolagsstämma 2012 |
2012-07-12 | Kvartalsrapport 2012-Q2 |
2012-05-03 | Kapitalmarknadsdag 2012 |
2012-04-27 | Kvartalsrapport 2012-Q1 |
2012-04-12 | Ordinarie utdelning ORX 0.00 SEK |
2012-04-11 | Årsstämma 2012 |
2012-01-31 | Bokslutskommuniké 2011 |
2011-11-09 | Kvartalsrapport 2011-Q3 |
2011-08-10 | Kvartalsrapport 2011-Q2 |
2011-05-04 | Kvartalsrapport 2011-Q1 |
2011-04-08 | Ordinarie utdelning ORX 0.00 SEK |
2011-04-07 | Årsstämma 2011 |
2011-02-16 | Bokslutskommuniké 2010 |
2011-02-16 | Extra Bolagsstämma 2011 |
2010-11-10 | Kvartalsrapport 2010-Q3 |
2010-08-20 | Kvartalsrapport 2010-Q2 |
2010-05-05 | Kvartalsrapport 2010-Q1 |
2010-04-22 | Ordinarie utdelning ORX 0.00 SEK |
2010-04-21 | Årsstämma 2010 |
2010-02-17 | Bokslutskommuniké 2009 |
2009-11-10 | Kvartalsrapport 2009-Q3 |
2009-08-21 | Kvartalsrapport 2009-Q2 |
2009-05-06 | Kvartalsrapport 2009-Q1 |
2009-04-24 | Ordinarie utdelning ORX 0.00 SEK |
2009-04-23 | Årsstämma 1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Uppsala, Sweden – January 30, 2024 – As previously communicated Orexo will announce the Full Year Report 2023, focusing on the development in the fourth quarter, on February 8, at 8 am CET.
The same day at 2 pm, analysts, investors, and media are invited to attend a presentation where Nikolaj Sørensen, CEO, and Fredrik Järrsten, CFO, will present the latest development and host a Q&A.
To attend via teleconference where you can ask questions verbally use this link:
https://conference.financialhearings.com/teleconference/?id=2001504
When registered you will be provided phone numbers and a conference ID to access the conference.
To attend via webcast:
https://ir.financialhearings.com/orexo-q4-2023
Prior to the event the presentation material will be available on the website under Investors/Reports, Presentations.
For further information, please contact:
Orexo AB (publ.)
Lena Wange, IR & Communications Director
Tel: +46 (0)18 780 88 00
Email: ir@orexo.com
About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.
For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on X (former Twitter), LinkedIn, and YouTube.